Home / Febuxostat / Czechia
CZ ATC M04AA03 · updated 2 Nov 2026
Febuxostat shortage in Czechia
Is there a Febuxostat shortage in Czechia?
Yes. As of 2 Nov 2026, 3 Febuxostat products are reported short in Czechia, the first since 5 Aug 2024. The company estimate for the return is 15 Nov 2026 (latest 31 Mar 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Ireland, Austria, Belgium. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | FEBUXOSTAT VIATRIS 80MG 80MG TBL FLM 84 KAL II | VIATRIS LIMITED, Dublin | 5 Aug 2024 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | FEBUXOSTAT VIATRIS 80MG 80MG TBL FLM 28 KAL II | VIATRIS LIMITED, Dublin | 21 Oct 2024 | 31 Mar 2027 | Manufacturing problem Výrobní důvody |
| CZ | ADENURIC 80MG 80MG TBL FLM 84 II | Menarini International Operations Luxembourg S.A., Luxembourg | 14 Sep 2026 | 15 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.